Related references
Note: Only part of the references are listed.Dual targeting of Hsp90 in childhood acute lymphoblastic leukaemia
Paraskevi Diamanti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma
Jimmy Lee et al.
BLOOD ADVANCES (2018)
Epigenetic transcriptional memory
Agustina D'Urso et al.
CURRENT GENETICS (2017)
Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2
Yueh-Chun Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma
Lisa Giulino-Roth et al.
MOLECULAR CANCER THERAPEUTICS (2017)
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma
Candace J. Poole et al.
ONCOTARGET (2017)
MYC-Master Regulator of the Cancer Epigenome and Transcriptome
Candace J. Poole et al.
GENES (2017)
Drugging the 'undruggable' cancer targets
Chi V. Dang et al.
NATURE REVIEWS CANCER (2017)
BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis
Laia Richart et al.
NATURE COMMUNICATIONS (2016)
Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells
Cristina Florean et al.
ONCOTARGET (2016)
DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance
Roland M. Huber et al.
ONCOTARGET (2015)
Acute response and subcellular movement of HSP27, αB-crystallin and HSP70 in human skeletal muscle after blood-flow-restricted low-load resistance exercise
K. T. Cumming et al.
ACTA PHYSIOLOGICA (2014)
Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice
E. Ikebe et al.
BLOOD CANCER JOURNAL (2013)
17-DMAG targets the nuclear factor-κB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
Erin Hertlein et al.
BLOOD (2010)
The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenance
Jan van Riggelen et al.
GENES & DEVELOPMENT (2010)
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
J. E. Lancet et al.
LEUKEMIA (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat A highly active combination against human mantle cell lymphoma (MCL) cells
Rekha Rao et al.
CANCER BIOLOGY & THERAPY (2009)
Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression
Muhammad Tariq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Hsp90 molecular chaperone: an open and shut case for treatment
Laurence H. Pearl et al.
BIOCHEMICAL JOURNAL (2008)
Oncogene addiction versus oncogene amnesia: Perhaps more than just a bad habit?
Dean W. Felsher
CANCER RESEARCH (2008)
Targeting Hsp90: small-molecule inhibitors and their clinical development
Tony Taldone et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells
K. Lin et al.
ONCOGENE (2008)
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
Chi-Hwa Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
CM Shachaf et al.
NATURE (2004)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
The many faces of c-MYC
S Pelengaris et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)
Unexpected induction of the human connexin 43 promoter by the Ras signaling pathway is mediated by a novel putative promoter sequence
GD Carystinos et al.
MOLECULAR PHARMACOLOGY (2003)
An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets
KI Zeller et al.
GENOME BIOLOGY (2003)
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
M Jain et al.
SCIENCE (2002)
Translocations involving c-myc and c-myc function
LM Boxer et al.
ONCOGENE (2001)
Molecular biology of Burkitt's lymphoma
JL Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
